P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY

• Sylvain Chantepie,
• Françoise Huguet,
• Mathilde Hunault,
• Gabrielle Roth Guepin,
• Marie Balsat,
• Maria Pilar Gallego Hernanz,
• Magalie Joris,
• Alexandre Karangwa,
• Mario Ojeda Uribe,
• Alberto Santagostino,
• Sébastien Maury

Affiliations

Sylvain Chantepie

1 CHU Caen, Institute of Hematology, Caen, France

Françoise Huguet

2 CHU Toulouse, IUCT, Hematology service, Toulouse, France

Mathilde Hunault

3 CHU Angers, Maladies du sang, Angers, France

Gabrielle Roth Guepin

6 CHRU Nancy, Department of Hematology, Nancy, France

Marie Balsat

7 CHU Lyon, Department of Hematology, Lyon, France

Maria Pilar Gallego Hernanz

8 CHU Poitiers, Department of Hematology and Cellular Therapy, Poitiers, France

Magalie Joris

9 CHU Amiens, Department of Hematology, Amiens, France

Alexandre Karangwa

10 CH Perpignan, Department of Hematology, Perpignan, France

Mario Ojeda Uribe

11 GHRMSA, Hôpital E Muller, Department of Hematology and Cellular Therapy Unit, Mulhouse, France

Alberto Santagostino

12 CH Troyes, Department of Hematology, Troyes, France

Sébastien Maury

13 Hôpital Henri Mondor, Clinical Hematology, Créteil, France